Building corporate partnerships
Our Corporate Partnerships division enables collaborations with academic organisations and charities that need assistance with intellectual property management and development.
We could collaborate with you to offer:
• Identification, protection and management of intellectual property;
• Development of drug and antibody targets via our Centre for Therapeutics Discovery; and
• Management of your pre-seed managed fund programme.
Find out about our current partners.
News feed
Barbara Saxty has co-authored a Nature Communications paper entitled An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid.
The University of Leicester is recruiting for an MRCT-supported Research Fellow
MRCT are collaborating with the University of Bristol to develop orally available small molecule TrkA antagonists for treatment of chronic intractable pain.
MRC Technology’s Therapeutic Antibody Group and The University of Aberdeen work together on project to develop therapeutic against a novel cancer target, soluble CTLA-4.